Summary
Updated Aug 31, 2026
Jonathan Kenneth Charles Knowles is Director of Caris Life Sciences, Inc. (CAI). 1 SEC Form 4 filing on record, dated 2 June 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Jonathan Kenneth Charles Knowles has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Jonathan Kenneth Charles Knowles go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jonathan Kenneth Charles Knowles files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jon Halbert - $990K of CAI open-market activity in the last 12 months
- Jeff L. Vacirca - $501K of CAI open-market activity in the last 12 months
- John Russel Denton - $101K of CAI open-market activity in the last 12 months
- David Baxley Spetzler - $10K of CAI open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jonathan Kenneth Charles Knowles?
Jonathan Kenneth Charles Knowles is a corporate insider, tracked as Director of Caris Life Sciences, Inc. (CAI). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jonathan Kenneth Charles Knowles submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Jonathan Kenneth Charles Knowles's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jonathan Kenneth Charles Knowles and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial